Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
Eva Futtrup Maksten,Rasmus Rask Kragh Jørgensen,Mathilde Selmar Pedersen,Kirsten Fonager,Rie Sander Bech,Ingolf Mølle,Andreas Due Ørskov,Claudia Schöllkopf,Ulrik Malthe Overgaard,Gunhild Nynke Thomsen,Tarec C El-Galaly,Marianne Tang Severinsen
DOI: https://doi.org/10.2147/clep.s444270
2024-03-14
Clinical Epidemiology
Abstract:Eva Futtrup Maksten, 1, 2, &ast Rasmus Rask Kragh Jørgensen, 1, 2, &ast Mathilde Selmar Pedersen, 1, 2 Kirsten Fonager, 2, 3 Rie Sander Bech, 1, 2 Ingolf Mølle, 4 Andreas Due Ørskov, 5 Claudia Schöllkopf, 6 Ulrik Malthe Overgaard, 6 Gunhild Nynke Thomsen, 7 Tarec C El-Galaly, 1, 2 Marianne Tang Severinsen 1, 2 1 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; 2 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 3 Department of Social Medicine, Aalborg University Hospital, Aalborg, Denmark; 4 Department of Hematology, Aarhus University Hospital, Aarhus, Denmark; 5 Department of Hematology, Zealand University Hospital, Roskilde, Denmark; 6 Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark; 7 Department of Hematology, Odense University Hospital, Odense, Denmark &astThese authors contributed equally to this work Correspondence: Eva Futtrup Maksten, Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Sdr. Skovvej 15, Aalborg, 9000, Denmark, Tel +45 97666864, Fax +45 97666323, Email Purpose: Most adult patients diagnosed with acute lymphoblastic leukemia (ALL) are below retirement age. The overall survival of patients with ALL has improved with implementation of high intensity pediatric-inspired treatment protocols. However, this treatment comes with a risk of long-term complications, which could affect the ability to work. The aim of this study was to investigate the risk of disability pension (DP) and return to work (RTW) for patients with ALL. Patients and Methods: Patients aged 18– 60 years diagnosed with ALL between 2005 and 2019 were identified in the Danish National Acute Leukemia Registry. Each patient was matched with five comparators from the general population on birth year, sex, and Charlson Comorbidity Index. The Aalen-Johansen estimator was used to calculate the cumulative risk of DP for patients and comparators from index date (defined as 1 year after diagnosis) with competing events (transplantation or relapse, death, retirement pension, or early retirement pension). Differences in cumulative incidences were calculated using Gray's test. RTW was calculated as proportions one, three, and five years after the index date for patients holding a job before diagnosis. Results: A total of 154 patients with ALL and 770 matched comparators were included. The 5-year cumulative risk of DP was increased fivefold for patients with ALL compared with the general population. RTW was 41.7%, 65.7%, and 60.7% one, three, and five years after the index date, respectively. Conclusion: The risk of DP in patients with ALL increased significantly compared with the general population. Five years after the index date, RTW was 60.7% for patients with ALL. Keywords: acute lymphoblastic leukemia, disability pension, return to work Acute lymphoblastic leukemia (ALL) is an aggressive hematologic malignancy. 1 The overall survival of younger adult patients with ALL has increased within the last 15 years, which is linked to the introduction of high intensity pediatric-inspired treatment protocols for adults, and risk-adapted treatment algorithms. 2–5 In Denmark, the median age at diagnosis is 56 years for adult patients with ALL. 6 Hence, a substantial number of patients with ALL are below the Danish retirement age of currently 67 years. The Danish welfare system provides economic compensation for Danish citizens who are sick or unable to work. In case of temporary health-related problems, sickness benefit will be granted until it is possible to return to work. People of working age who are permanently unable to work due to health-related issues can be granted a disability pension (DP). The risk of long-term sick leave and early retirement is higher in cancer patients than in the general population. 7,8 Studies furthermore suggest that the risk of DP is higher, and return to work (RTW) is lower in patients with acute leukemia compared with patients with a majority of other hematological malignancies. These studies, however, assessed patients with ALL and acute myeloid leukemia (AML) in combination and did not perform separate sub-group analyses for ALL and AML, respectively. 9,10 The ability to work for patients with ALL may be affected by long-term complications due to new, intensified chemotherapy regimens for ALL patients of working age leading to increased -Abstract Truncated-
public, environmental & occupational health